Grupo de investigacións biomédicas
GIBIOMED
![Foto de Grupo de investigacións biomédicas](/img/grupo.png)
![Foto de Complexo Hospitalario Universitario da Coruña](/img/noimage_org.png)
Complexo Hospitalario Universitario da Coruña
La Coruña, EspañaPublikationen in Zusammenarbeit mit Forschern von Complexo Hospitalario Universitario da Coruña (19)
2023
-
Ambient temperature modulates body weight changes in patients with advanced oncological diseases and anorexia cachexia syndrome
International Journal of Biometeorology, Vol. 67, Núm. 9, pp. 1451-1459
2009
-
Regulation of visceral adipose tissue-derived serine protease inhibitor by nutritional status, metformin, gender and pituitary factors in rat white adipose tissue
Journal of Physiology, Vol. 587, Núm. 14, pp. 3741-3750
-
Vaspin and amylin are expressed in human and rat placenta and regulated by nutritional status
Histology and Histopathology, Vol. 24, Núm. 8, pp. 979-990
2008
-
Food intake regulating-neuropeptides are expressed and regulated through pregnancy and following food restriction in rat placenta
Reproductive Biology and Endocrinology, Vol. 6
-
Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain
European Journal of Endocrinology, Vol. 159, Núm. 5, pp. 623-631
2006
-
Effect of acute ghrelin administration on glycaemia and insulin levels in obese patients
Diabetes, Obesity and Metabolism, Vol. 8, Núm. 5, pp. 555-560
2004
-
Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients
Clinical Endocrinology, Vol. 61, Núm. 2, pp. 250-255
2003
-
Diagnosis of growth hormone deficiency after pituitary surgery: The combined acipimox/GH-releasing hormone test
Clinical Endocrinology, Vol. 58, Núm. 2, pp. 156-162
-
Effect of acute reduction of free fatty acids by acipimox on growth hormone-releasing hormone-induced GH secretion in type 1 diabetic patients
Clinical Endocrinology, Vol. 59, Núm. 4, pp. 431-436
2002
-
Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity
Clinical Endocrinology, Vol. 56, Núm. 4, pp. 487-492
-
Effect of withdrawal of somatostatin plus growth hormone (GH)-releasing hormone as a stimulus of GH secretion in Cushing's syndrome
Clinical Endocrinology, Vol. 57, Núm. 6, pp. 745-749
2001
-
Effect of acute pharmacological modulation of plasma free fatty acids on GH secretion in acromegalic patients
Clinical Endocrinology, Vol. 54, Núm. 4, pp. 509-513
1999
-
Regulation of growth hormone secretion by signals produced by the adipose tissue
Journal of Endocrinological Investigation, Vol. 22, Núm. 5 SUPPL., pp. 22-26
-
Serum leptin levels in women throughout pregnancy and the postpartum period and in women suffering spontaneous abortion
Clinical Endocrinology, Vol. 50, Núm. 2, pp. 211-216
1998
-
Acute changes in free-fatty acids (FFA) do not alter serum leptin levels
Journal of Endocrinological Investigation, Vol. 21, Núm. 8, pp. 526-530
-
Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism
Journal of Clinical Endocrinology and Metabolism, Vol. 83, Núm. 12, pp. 4350-4354
1995
-
Effect of combined administration of growth hormone (GH)-releasing hormone, GH-releasing peptide-6, and pyridostigmine in normal and obese subjects
Metabolism, Vol. 44, Núm. 6, pp. 745-748
1994
-
Physiopathology of hypophyseal tumors secreting growth hormone, prolactin and glycoproteins
Anales de medicina interna (Madrid, Spain : 1984), Vol. 11, Núm. 2, pp. 89-94
1991
-
Study of insulin-like growth factor I in human obesity
Hormone Research in Paediatrics, Vol. 36, Núm. 5-6, pp. 187-191